NCT07373145

Brief Summary

This prospective, multicenter observational cohort study aims to investigate changes in target lesion hemodynamic parameters, diameter stenosis, plaque characteristics of CCTA before and after the DCB procedure and evaluate their association with clinical outcomes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
165

participants targeted

Target at P50-P75 for all trials

Timeline
80mo left

Started Aug 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Aug 2025Dec 2032

Study Start

First participant enrolled

August 1, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

August 8, 2025

Completed
6 months until next milestone

First Posted

Study publicly available on registry

January 28, 2026

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2031

Expected
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2032

Last Updated

January 28, 2026

Status Verified

January 1, 2026

Enrollment Period

6 years

First QC Date

August 8, 2025

Last Update Submit

January 22, 2026

Conditions

Keywords

drug coated balloonCCTAcoronary artery disease

Outcome Measures

Primary Outcomes (1)

  • Changes in ΔFFR CT before and after DCB procedure

    From baseline CCTA to follow-up CCTA performed 2 years after the index PCI

Secondary Outcomes (2)

  • Changes in plaque characteristics before and after DCB procedure

    From baseline CCTA to follow-up CCTA performed 2 years after the index PCI

  • Changes in diameter stenosis before and after DCB procedure

    From baseline CCTA to follow-up CCTA performed 2 years after the index PCI

Study Arms (1)

Patients treated with a drug-coated balloon for de novo lesions.

Patients who underwent DCB within 3 months after CCTA and whose clinical presentation remained largely unchanged from the time of CCTA.

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who took coronary computed tomography angiography (CCTA) and received drug-coated balloon (DCB) treatment for coronary artery disease

You may qualify if:

  • Patients with Age ≥ 19
  • Patients who took CCTA and were found to have coronary artery disease requiring reperfusion
  • Patients who underwent DCB within 3 months after CCTA and whose clinical presentation remained largely unchanged from the time of CCTA.
  • The target lesion is a de novo lesion with a vessel diameter between 2.25mm and 3.00mm
  • Patients deemed suitable for coronary intervention using drug-coated balloon by clinical assessment
  • Patients who have been adequately informed about this study and have voluntarily provided written consent to participate.

You may not qualify if:

  • The target lesion is an in-stent restenosis lesion
  • Patient requiring emergency salvage stenting in target lesion
  • Patients with a stent previously implanted in the same vessel
  • Lesions involving chronic total occlusion or prior coronary artery bypass grafting (CABG).
  • Patients with eGFR (estimated glomerular filtration rate) \< 45 ml/min/1.73mm2
  • Patients with coronary artery calcium score ≥ 1000 as determined by CCTA
  • Patients with an expected survival of less than 5 years
  • Pregnant or breastfeeding patients
  • Patients deemed inappropriate to participate in this study based on the judgment of study investigators

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, South Korea

RECRUITING

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Central Study Contacts

Bon-kwon Koo, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 8, 2025

First Posted

January 28, 2026

Study Start

August 1, 2025

Primary Completion (Estimated)

August 1, 2031

Study Completion (Estimated)

December 1, 2032

Last Updated

January 28, 2026

Record last verified: 2026-01

Locations